PI3Kβ inhibition blocks ALK‐inhibition‐induced cytoprotective reactivation of EGFR signaling, enhancing the cytotoxic effect on both epithelial‐ and mesenchymal‐phenotype cancer cells without affecting normal lung epithelial cells. This evidence concerns the gene EGFR and cancer.